Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical utility of testing for antineutrophil cytoplasmic antibodies.

× No keyword cloud information.

69 in total

1. Anti-neutrophil cytoplasm antibodies and anti-glomerular basement membrane antibodies: two coexisting distinct autoreactivities detectable in patients with rapidly progressive glomerulonephritis.

Authors: A K Short; V L Esnault; C M Lockwood
Journal: Am J Kidney Dis Date: 1995-09 Impact factor: 8.860

Review 2. Animal models of anti-neutrophil cytoplasmic antibody associated vasculitis.

Authors: P Heeringa; E Brouwer; J W Tervaert; J J Weening; C G Kallenberg
Journal: Kidney Int Date: 1998-02 Impact factor: 10.612

3. Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damage.

Authors: W H Schmitt; E Csernok; S Kobayashi; A Klinkenborg; E Reinhold-Keller; W L Gross
Journal: Arthritis Rheum Date: 1998-03

4. Clinical and laboratory features of myelitis patients with anti-neutrophil cytoplasmic antibodies.

Authors: I Nakashima; K Fujihara; M Endo; H Seki; N Okita; S Takase; Y Itoyama
Journal: J Neurol Sci Date: 1998-04-15 Impact factor: 3.181

5. Mixed cryoglobulinaemia, glomerulonephritis, and ANCA: essential cryoglobulinaemic vasculitis or ANCA-associated vasculitis?

Authors: P Lamprecht; W H Schmitt; W L Gross
Journal: Nephrol Dial Transplant Date: 1998-01 Impact factor: 5.992

6. Capture-ELISA based on recombinant PR3 is sensitive for PR3-ANCA testing and allows detection of PR3 and PR3-ANCA/PR3 immunecomplexes.

Authors: J Sun; D N Fass; J A Hudson; M A Viss; J Wieslander; H A Homburger; U Specks
Journal: J Immunol Methods Date: 1998-02-01 Impact factor: 2.303

7. Anti-neutrophil cytoplasmic antibodies in childhood systemic lupus erythematosus.

Authors: S N Wong; V Shah; M J Dillon
Journal: Eur J Pediatr Date: 1995-01 Impact factor: 3.183

8. Screening for anti-neutrophil cytoplasmic antibodies (ANCA): is indirect immunofluorescence the method of choice?

Authors: B Baslund; M Segelmark; A Wiik; W Szpirt; J Petersen; J Wieslander
Journal: Clin Exp Immunol Date: 1995-03 Impact factor: 4.330

9. Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Prevalence, specificities, and clinical significance.

Authors: A Schnabel; E Csernok; D A Isenberg; C Mrowka; W L Gross
Journal: Arthritis Rheum Date: 1995-05

3. Antineutrophil Cytoplasmic Antibody Induction due to Infection: A Patient with Infective Endocarditis and Chronic Hepatitis C.

Authors: Fareed B Kamar; T Lee-Ann Hawkins
Journal: Can J Infect Dis Med Microbiol Date: 2016-03-21 Impact factor: 2.471

3 in total

Clinical utility of testing for antineutrophil cytoplasmic antibodies.